FDA.reportPublic FDA data

Application 206791

Type
ANDA
Sponsor
SOMERSET THERAPS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CISATRACURIUM BESYLATE PRESERVATIVE FREECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 2MG BASE/MLNoNo
002CISATRACURIUM BESYLATE PRESERVATIVE FREECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 10MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70069-141Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-141Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-141Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-141Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-151Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-151Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-151Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent
70069-151Cisatracurium BesylateCisatracurium BesylateSomerset Therapeutics, LLCANDACurrent